IVERIC bio (ISEE) Reports Q4 Loss of $0.39/Share

Go back to IVERIC bio (ISEE) Reports Q4 Loss of $0.39/Share

IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results

February 27, 2020 7:00 AM EST

- Conference Call and Webcast Today, February 27, 2020, at 8:00 a.m. ET -

NEW YORK--(BUSINESS WIRE)-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial and operating results for the fourth quarter and full year ended December 31, 2019 and provided a general business update.

We made... More